Concord Drugs Ltd
Concord Drugs Ltd Live Price Chart
Performance
| Previous Close | ₹ 74 |
| High | ₹ 79.5 |
| Volume | 9471 |
| 52W Range | ₹ 61 - ₹ 92.52 |
| Open | ₹ 76.89 |
| Low | ₹ 76.89 |
| Market Cap | ₹ 103.71 Cr |
Concord Drugs Ltd Technicals
| 20 Day | ₹ 77.366 |
| 50 Day | ₹ 76.458 |
| 100 Day | ₹ 76.320 |
| 200 Day | ₹ 74.159 |
| 20 Day | ₹ 79.056 |
| 50 Day | ₹ 74.684 |
| 100 Day | ₹ 76.863 |
| 200 Day | ₹ 77.911 |
Concord Drugs Ltd Fundamentals
| ROCE | 4.824 |
| P/E Ratio | 51.040 |
| P/B Ratio | 2.230 |
| Industry P/E | 2.230 |
| Debt to Equity | 51.566 |
| ROE | 2.138 |
| EPS | 1.550 |
| Dividend Yield | 0.000 |
| Book Value | 35.428 |
| Face Value | 10.000 |
Concord Drugs Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 75.883 | 36.9465 | 43.27 | 51.3232 | 59.0573 |
| Total Expenses | 74.4344 | 36.3052 | 42.7116 | 50.1976 | 56.8092 |
| Profit After Tax | 1.0374 | 0.2957 | 0.4194 | 0.8922 | 1.5943 |
Concord Drugs Ltd Shareholding Pattern
| Promoter Holdings | 45.079 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 54.190 % |
| Others - | 0.731 % |
About Concord Drugs Ltd
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 40.05 +1.23 (+3.17%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 509.00 +8.75 (+1.75%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,710.00 -2.15 (-0.03%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 695.00 +4.6 (+0.67%) |
| Abbott India Ltd Pharmaceuticals | ₹ 27,000.00 -223.2 (-0.82%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,380.00 -1 (-0.07%) |
FAQs on Concord Drugs Ltd
1. Can I buy Concord Drugs Ltd from PL Capital? ›
2. Does Concord Drugs Ltd pay dividends? ›
3. What is the current share price of Concord Drugs Ltd ? ›
4. What is the 52-week high and low of Concord Drugs Ltd ? ›
5. What is the market capitalisation of Concord Drugs Ltd? ›
6. What is the current P/E ratio of Concord Drugs Ltd? ›
7. What is the current P/B ratio of Concord Drugs Ltd? ›
8. What is the shareholding pattern of Concord Drugs Ltd? ›
9. What is the 1-year return of Concord Drugs Ltd? ›
Start SIP in Concord Drugs Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
